Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Journey Medical (DERM) Return on Equity: 2021-2024

Historic Return on Equity for Journey Medical (DERM) over the last 4 years, with Dec 2024 value amounting to -0.73%.

  • Journey Medical's Return on Equity rose 127.00% to -0.38% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.38%, marking a year-over-year increase of 127.00%. This contributed to the annual value of -0.73% for FY2024, which is 52.00% down from last year.
  • According to the latest figures from FY2024, Journey Medical's Return on Equity is -0.73%, which was down 251.71% from -0.21% recorded in FY2023.
  • Over the past 5 years, Journey Medical's Return on Equity peaked at -0.21% during FY2023, and registered a low of -1.68% during FY2021.
  • Over the past 3 years, Journey Medical's median Return on Equity value was -0.73% (recorded in 2024), while the average stood at -0.65%.
  • As far as peak fluctuations go, Journey Medical's Return on Equity skyrocketed by 80bps in 2023, and later tumbled by 52bps in 2024.
  • Over the past 4 years, Journey Medical's Return on Equity (Yearly) stood at -1.68% in 2021, then skyrocketed by 68bps to -1.00% in 2022, then spiked by 80bps to -0.21% in 2023, then tumbled by 52bps to -0.73% in 2024.